文献速递衰弱、肌少症与跌倒老年慢病共病管理

慢性阻塞性肺疾病合并肌少症患者骨骼肌中肌生成与蛋白周转信号增强

Increased Myogenic and Protein Turnover Signaling in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients With Sarcopenia.
PubMed 文献 · J Am Med Dir Assoc · 2017-05-31

该研究对比了合并与不合并肌少症的慢性阻塞性肺疾病(COPD)患者及健康对照的股外侧肌活检,发现COPD患者泛素-蛋白酶体调节、自噬和蛋白合成信号增强,且在肌少症COPD患者中更明显,同时肌生成信号亦升高。

要点

  • COPD患者骨骼肌自噬、蛋白合成及部分泛素-蛋白酶体调节信号增强。
  • 上述分子改变在合并肌少症的COPD患者中更为显著。
  • COPD患者肌生成信号增强,但与是否合并肌少症无关。

核心结论

  • COPD患者骨骼肌蛋白周转信号增强并伴肌生成信号升高,合并肌少症者改变更突出,反映肌肉修复与重塑相关的分子改变。

研究设计与样本

  • 研究获取股外侧肌活检,将COPD患者按低四肢骨骼肌质量指数定义的肌少症分为非肌少症COPD组(n=53)和肌少症COPD组(n=39),并与健康非肌少症对照组(n=13)比较。

主要发现

  • 泛素-蛋白酶体系统信号未改变,但泛素-蛋白酶体调节指标、自噬信号和蛋白合成信号在COPD中增加。
  • 上述改变在合并肌少症的COPD患者中更为明显,涉及FOXO1蛋白、p-FOXO1/FOXO1、LC3BII/I、p-ULK(Ser555)、p-AKT1/AKT1、AKT1和p-4E-BP1等指标。
  • COPD患者肌生成信号(如MYOG)增加,同时肌肉生长抑制素(MSTN)mRNA表达也升高,但肌少症与非肌少症COPD患者间无差异。

临床怎么用

  • 对COPD患者应关注肌少症评估,合并肌少症者可能存在更显著的骨骼肌蛋白周转信号改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sarcopenia was recently recognized as an independent condition by an International Classification of Diseases, Tenth Revision, Clinical Modification code, and is a frequently observed comorbidity in chronic obstructive pulmonary disease (COPD). Muscle mass is primarily dictated by the balance between protein degradation and synthesis, but their relative contribution to sarcopenia is unclear. OBJECTIVE: We aimed to assess potential differential molecular regulation of protein degradation and synthesis, as well as myogenesis, in the skeletal muscle of COPD patients with and without sarcopenia. METHODS: Muscle biopsies were obtained from the vastus lateralis muscle. Patients with COPD were clustered based on sarcopenia defined by low appendicular skeletal muscle mass index (nonsarcopenic COPD, n = 53; sarcopenic COPD, n = 39), and compared with healthy nonsarcopenic controls (n = 13). The mRNA and protein expression of regulators and mediators of ubiquitin-proteasome system (UPS), autophagy-lysosome system (autophagy), and protein synthesis were analyzed. Furthermore, mRNA expression of myogenesis markers was assessed. RESULTS: UPS signaling was unaltered, whereas indices of UPS regulation (eg, FOXO1 protein; p-FOXO3/FOXO3), autophagy signaling (eg, LC3BII/I; p-ULK1[Ser757]/ULK1), and protein synthesis signaling (eg, AKT1; p-GSK3B/GSK3B; p-4E-BP1/4E-BP1) were increased in COPD. These alterations were even more pronounced in COPD patients with sarcopenia (eg, FOXO1 protein; p-FOXO1/FOXO1; LC3BII/I; p-ULK(Ser555); p-AKT1/AKT1; AKT1; p-4E-BP1). Furthermore, myogenic signaling (eg, MYOG) was increased in COPD despite a concomitant increase of myostatin (MSTN) mRNA expression, with no difference between sarcopenic and nonsarcopenic COPD patients. CONCLUSION: Together with elevated myogenic signaling, the increase in muscle protein turnover signaling in COPD, which is even more prominent in COPD patients with sarcopenia, reflects molecular alterations associated with muscle repair and remodeling.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Kneppers AEM, Langen RCJ, Gosker HR, et al. Increased Myogenic and Protein Turnover Signaling in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients With Sarcopenia. J Am Med Dir Assoc. 2017. PMID: 28578881. doi:10.1016/j.jamda.2017.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。